PL3604303T3 - Nowa pochodna pirolopirydyny, sposób jej wytwarzania oraz jej zastosowanie - Google Patents

Nowa pochodna pirolopirydyny, sposób jej wytwarzania oraz jej zastosowanie

Info

Publication number
PL3604303T3
PL3604303T3 PL17901680.3T PL17901680T PL3604303T3 PL 3604303 T3 PL3604303 T3 PL 3604303T3 PL 17901680 T PL17901680 T PL 17901680T PL 3604303 T3 PL3604303 T3 PL 3604303T3
Authority
PL
Poland
Prior art keywords
producing same
pyrrolopyridine derivative
novel pyrrolopyridine
novel
derivative
Prior art date
Application number
PL17901680.3T
Other languages
English (en)
Inventor
Bong Jin Kim
Ill Young Lee
Jae Hak Kim
Hong Suk Shin
Jong Chan Son
Chong-Kyo Lee
Kyungjin Kim
Uk-Il KIM
Hwa Jung Nam
Original Assignee
St Pharm Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Pharm Co., Ltd. filed Critical St Pharm Co., Ltd.
Publication of PL3604303T3 publication Critical patent/PL3604303T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL17901680.3T 2017-03-24 2017-03-24 Nowa pochodna pirolopirydyny, sposób jej wytwarzania oraz jej zastosowanie PL3604303T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2017/003194 WO2018174320A1 (ko) 2017-03-24 2017-03-24 신규한 피롤로피리딘 유도체, 이의 제조방법 및 용도

Publications (1)

Publication Number Publication Date
PL3604303T3 true PL3604303T3 (pl) 2023-04-11

Family

ID=63584472

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17901680.3T PL3604303T3 (pl) 2017-03-24 2017-03-24 Nowa pochodna pirolopirydyny, sposób jej wytwarzania oraz jej zastosowanie

Country Status (16)

Country Link
US (1) US11214570B2 (pl)
EP (1) EP3604303B1 (pl)
JP (1) JP6781848B2 (pl)
KR (1) KR102148294B1 (pl)
CN (1) CN110461837B (pl)
AU (1) AU2017405244C9 (pl)
CA (1) CA3057586C (pl)
DK (1) DK3604303T3 (pl)
ES (1) ES2938335T3 (pl)
HU (1) HUE061404T2 (pl)
MX (1) MX391856B (pl)
PL (1) PL3604303T3 (pl)
PT (1) PT3604303T (pl)
RU (1) RU2733723C1 (pl)
WO (1) WO2018174320A1 (pl)
ZA (1) ZA201906848B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3519409B1 (en) 2016-09-28 2024-09-18 Gilead Sciences, Inc. Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
KR102909106B1 (ko) * 2020-08-20 2026-01-07 에스티팜 주식회사 피롤로피리딘 유도체 및 이들의 용도
EP4276101B1 (en) * 2021-01-11 2026-03-04 ST Pharm Co., Ltd. Pyrrolopyridine derivative preparation method
EP4671241A1 (en) * 2023-02-20 2025-12-31 ST Pharm Co., Ltd. CRYSTALLINE FORM OF PYRROLOPYRIDINE DERIVATIVE
WO2025159574A1 (ko) * 2024-01-25 2025-07-31 에스티팜 주식회사 피롤로피리딘 화합물 및 이들의 용도
WO2025244507A1 (en) * 2024-05-22 2025-11-27 St Pharm Co., Ltd. Pyrrolopyridine derivatives for curing hiv infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510319A (pt) * 2004-04-26 2007-10-16 Pfizer inibidores da enzima integrase de hiv
US8354429B2 (en) * 2007-11-16 2013-01-15 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
CA2762680C (en) 2009-05-21 2018-04-17 Chlorion Pharma, Inc. Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
JP6055468B2 (ja) * 2011-07-15 2016-12-27 ヴィーブ ヘルスケア ユーケー リミテッド アザインドール化合物及びhivを治療するための方法
WO2013073875A1 (ko) 2011-11-15 2013-05-23 한국화학연구원 신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법
ES2647437T3 (es) * 2012-07-12 2017-12-21 Viiv Healthcare Uk Limited Compuestos y procedimientos para tratar el VIH
JP2015524653A (ja) 2012-07-13 2015-08-27 ロレアル 対象における薄皮状態のインビトロ診断方法及び関連用途
KR101592370B1 (ko) * 2014-06-09 2016-02-11 한국화학연구원 신규한 피롤로피리딘 유도체 및 이의 hiv 저해제로서의 용도

Also Published As

Publication number Publication date
RU2733723C1 (ru) 2020-10-06
CA3057586A1 (en) 2018-09-27
ES2938335T3 (es) 2023-04-10
US11214570B2 (en) 2022-01-04
PT3604303T (pt) 2023-02-14
EP3604303B1 (en) 2023-01-18
US20200377498A1 (en) 2020-12-03
AU2017405244C9 (en) 2021-03-04
KR20190141152A (ko) 2019-12-23
JP2020511482A (ja) 2020-04-16
DK3604303T3 (da) 2023-02-06
AU2017405244C1 (en) 2021-02-11
KR102148294B1 (ko) 2020-08-26
JP6781848B2 (ja) 2020-11-04
HUE061404T2 (hu) 2023-06-28
WO2018174320A1 (ko) 2018-09-27
CN110461837B (zh) 2022-06-17
ZA201906848B (en) 2021-06-30
AU2017405244A1 (en) 2019-11-07
AU2017405244B2 (en) 2020-10-01
BR112019019982A2 (pt) 2020-04-28
CN110461837A (zh) 2019-11-15
AU2017405244B9 (en) 2020-10-22
MX2019011220A (es) 2019-11-01
CA3057586C (en) 2022-05-03
EP3604303A4 (en) 2020-10-07
MX391856B (es) 2025-03-21
EP3604303A1 (en) 2020-02-05

Similar Documents

Publication Publication Date Title
PT3486242T (pt) Derivado de oxopicolinamida, método de preparação para esse fim e utilização farmacêutica do mesmo
PT3546457T (pt) Derivado de pirazolo-heteroarílico, método de preparação e a utilização médica do mesmo
IL269036A (en) TYK2 inhibitors, uses and methods for their production
EP3222644A4 (en) Polyurethane, preparing method therefor, and use thereof
PL3181560T3 (pl) Pochodna pirydynoamidopirymidyny, sposób jej otrzymywania i zastosowanie
ZA201906848B (en) Novel pyrrolopyridine derivative, method for producing same, and use thereof
ZA202001141B (en) Zeolite after treatment method
ZA201906079B (en) Novel ester compounds, method for the production thereof and use thereof
EP3612505C0 (de) Pedosphärenverbessernde granulate, herstellungsverfahren und verwendung
ZA202002138B (en) Method for preparing oxaspirocycle derivative, and intermediate thereof
EP3246327A4 (en) 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof
ZA201905065B (en) Novel ester compounds, method for the production thereof and use thereof
EP3309138A4 (en) Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
HUE058909T2 (hu) Etomidátszármazék és köztitermék, eljárás elõállítására és alkalmazása
PL3858833T3 (pl) Pochodna aminonorbornanu oraz sposób jej wytwarzania i zastosowanie
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
EP3398943A4 (en) Method for producing 1,2,3,5,6-pentathiepane
SG11201709899QA (en) Microorganism producing o-acetyl-homoserine, and method for producing o-acetyl-homoserine by using same
EP3263572A4 (en) Method for producing kakeromycin and derivatives thereof
SG11202003954QA (en) Method for producing dihydroxyindoles
EP3421463A4 (en) NEW TOXIN AND METHOD FOR PRODUCING AN INTERMEDIATE PRODUCT THEREOF
IL250223B (en) A method for the preparation of the pyrimidine-1-ol compound, and its intermediates
GB2546498B (en) Novel crystalline form of picoxystrobin, method of preparing and use of the same
EP3721886C0 (en) THERAPEUTIC METHOD